James E. Flynn - Jul 31, 2025 SCHEDULE 13D/A Report for Larimar Therapeutics, Inc. Common Stock, par value $0.0001 per share (LRMR)

Filing Manager
Flynn James E
Reporting Manager
Deerfield Management Company, L.P.
Security
Larimar Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
LRMR
Shares outstanding
85.6M shares
Disclosed Ownership
30.7M shares
Ownership
35.8%
Form type
SCHEDULE 13D/A
Date filed
7/31/2025, 06:26 PM
Date of event
Jul 31, 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deerfield Private Design Fund III, L.P. 11.14% 9.54M 0 9.54M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001603333
Deerfield Healthcare Innovations Fund, L.P. 8.55% 7.32M 0 7.32M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001646981
Deerfield Private Design Fund IV, L.P. 11.14% 9.54M 0 9.54M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001680307
Deerfield Partners, L.P. 4.91% 4.21M 0 4.21M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001301041
Deerfield Mgmt III, L.P. 11.14% 9.54M 0 9.54M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001610540
Deerfield Mgmt HIF, L.P. 8.55% 7.32M 0 7.32M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001665736
Deerfield Mgmt IV, L.P. 11.14% 9.54M 0 9.54M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001713467
Deerfield Mgmt, L.P. 4.91% 4.21M 0 4.21M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001010823
Deerfield Management Company, L.P. 35.81% 30.7M 0 30.7M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001009258
James E. Flynn 35.81% 30.7M 0 30.7M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001352546